The World Antimicrobial Resistance Congress is more than just an event – it's an opportunity to meet up with all stakeholders in the AMR space to brainstorm ideas and formulate initiatives that can effectively tackle antimicrobial resistance.
Since 2015, the World Antimicrobial Resistance Congress has attracted top thought leaders, hospitals, companies, and policymakers as the annual, go-to event in the Antimicrobial Resistance (AMR) space. We have grown into the most impactful event in advancing solutions to combat current and future pressing global health crises.
Whether you're in infection control & prevention, antimicrobial stewardship, one-health, manufacturing & sustainability, antibiotic R&D, diagnostics, vaccines, genomics & surviellance, or antibiotic commercialization – there's content tailored just for you.
Sponsors & Exhibitors
Steams of Content
Full days of Content
Job titles include: CEOs, VP of Infectious Diseases, VP of Antibiotic Development, Chief Medical Officers, Chief Scientific Officers, VP of R&D, Chief Business Officers, VP/Director of Microbiology, etc
Job titles include: Chiefs of Infectious Diseases, Chiefs of Pediatric Infectious Diseases, Directors of Infections Control, Directors of Antimicrobial Stewardship, Infectious Diseases Clinical Pharmacist
Services and solutions include: point-of-care diagnostics, susceptibility testing, CROs, antimicrobial stewardship and surveillance, and strategic consulting
Organizations include: HHS, FDA, CDC, NIH (NIAID), Public Health Agency of Canada, BARDA, CARB-X, IMI, and US House of Representatives
Including: American Society for Microbiology, Infectious Disease Society of America, and Society of Infectious Disease Pharmacists
Including: CARB-X, The Repair Fund, European Investment Bank, Thiel Capital, Medpro Investors, Hadean Ventures, Tekla Capital Management, Hadean Ventures, etc.